Short- and Long-Term Risks of Atrial Fibrillation in Lung Cancer Survivors According to Treatment Modality: A Korean Nationwide Study

Dong Woog Yoon, MD, PhD a, Jinhyung Jung, PhD b, Hyun Sung Joh, MD c, Seonghye Kim, MD, PhD d, Wonyoung Jung, MD, PhD, MSc e, Yong‑Moon Mark Park f, g, Kyungdo Han, PhD h, Dong Wook Shin, MD, DrPH, MBA d,i†, Jong Ho Cho, MD, PhD j† a Department of Thoracic and Cardiovascular Surgery, Chung-ang University Hospital, Seoul, Korea b Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea c Department of Internal Medicine and Cardiovascular Center, Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea d Department of Family Medicine & Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea e Division of Cardiology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA f Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, USA. g Cancer Prevention and Population Sciences Research Program, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA. h Department of Medical Statistics, The Catholic University of Korea, Seoul, Korea i Department of Digital Health, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, Korea j Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

첨부파일 : 2025 KTCVS Abstract AF_LCA.pdf

책임저자: Jong Ho Cho

성균관대학교 삼성서울병원

발표자: Dong Woog Yoon, E-mail : yoondw86@naver.com